Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Association Between Immune-Related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell CarcinomaIn Vivo 2020 Sep 01;34(5)2647-2652, K Kobayashi, Y Iikura, M Hiraide, T Yokokawa, T Aoyama, S Shikibu, K Hashimoto, K Suzuki, H Sato, E Sugiyama, M Tajima, T Hama
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.